PlexusDx Review

Best for: Shoppers wanting nationwide compounded GLP-1 with optional genetic-test personalization

PlexusDx (plexusdx.com) is a US GLP-1 telehealth platform offering compounded weight-loss medications with licensed providers in all 50 states. Programs include a microdose GLP-1 from $129/month, compounded semaglutide from $149/month, compounded tirzepatide from $249/month, and a combination GLP-Squared protocol. An independent US-licensed clinician reviews each patient via a state-licensed telehealth platform, and medications come from state-licensed pharmacies. PlexusDx is distinctive for an optional Precision Peptide genetic test (151 insights) discounted to $99 after a first order.

By Eli Marsden · Founding Editor
Editorially reviewed (not clinically reviewed) · How we verify contentLast reviewed

Medium confidence · Last verified 2026-06-04 · How we verify provider data

6.9
★★★3.5
Compounded semaglutideCompounded tirzepatideMicrodose GLP-1 optionOptional genetic panelLicensed in 50 statesState-licensed pharmaciesGLP-Squared comboTelehealth intake

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

The Bottom Line

PlexusDx is a solid telehealth option with balanced features and pricing.

Score: 6.9/10Best for: Shoppers wanting nationwide compounded GLP-1 with optional genetic-test personalizationFrom: $129/mo

Score Breakdown

Value
7
Effectiveness
7
User Experience
7
Trust & Safety
6.5
Accessibility
7.5
Support
6.5

Drugs Offered

PlexusDx prescribes the following GLP-1 medications. Tap a drug to read our clinical guide with FDA label info, dosing schedules, side effects, and trial data.

Pricing

DoseFormPrice/mo
Microdose GLP-1 monthlycompounded$129
Compounded semaglutide startingcompounded$149
Compounded tirzepatide startingcompounded$249

Pros

  • Licensed providers available in all 50 states
  • Range of options including low-cost microdose GLP-1 from $129/mo
  • Optional Precision Peptide genetic panel adds a personalization angle
  • Independent clinician review via state-licensed telehealth platform
  • Compounded medications from state-licensed pharmacies

Cons

  • Compounded medications only; no FDA-approved brand options
  • Specific compounding pharmacies not named
  • Genetic-panel upsell may not add clinical value for everyone
  • Tirzepatide pricing from $249/mo is higher than budget rivals
  • No insurance accepted

Ready to start with PlexusDx?

Starting at $129/month. See current pricing and start your free consultation.

Sources & methodology

Our PlexusDx review applies the same 6-dimension scoring framework we use for every provider. Pricing, FDA approval status, compounding rules, and clinical-trial efficacy claims are sourced from the primary regulatory and peer-reviewed literature below.

Sources & methodology — as of June 2026
  1. 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)WeightLossRankings.org.
  2. 2.FDA — Compounding and the 503A Pharmacy FrameworkU.S. Food & Drug Administration.
  3. 3.FDA — Drug Shortages Database (current shortage listings)U.S. Food & Drug Administration.
  4. 4.PCAB — Pharmacy Compounding Accreditation Board StandardsAccreditation Commission for Health Care (ACHC) / PCAB.
  5. 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)Kaiser Family Foundation.
  6. 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)New England Journal of Medicine.PMID: 33567185.
  7. 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDAU.S. Food & Drug Administration.
  8. 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDAU.S. Food & Drug Administration.
  9. 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)New England Journal of Medicine.PMID: 35658024.
  10. 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDAU.S. Food & Drug Administration.
  11. 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDAU.S. Food & Drug Administration.
  12. 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)New England Journal of Medicine.PMID: 40334173.

Alternatives to PlexusDx

7.6/ 10

Belle Health

Best for: flat-rate compounded GLP-1 with free weekly dietitian sessions

★★★3.8

Editorial score · methodology

$119/mo
CompoundedSemaglutideTirzepatideLegitScript VerifiedFDA Warning
Get StartedRead full Belle Health review →
7.1/ 10
Verified partner

bmiMD

Best for: mainstream telehealth GLP-1 access

★★★3.6

Editorial score · methodology

Get StartedRead full bmiMD review →
7.9/ 10
Verified partner

Bodybuilding Health+

Best for: fitness-brand compounded GLP-1 with hormone and performance programs

★★★★4

Editorial score · methodology

$179/mo
CompoundedSemaglutideTirzepatideLegitScript Verified
Get StartedRead full Bodybuilding Health+ review →

Frequently Asked Questions

Glossary references

Key terms in this article, linked to their canonical definitions.

Ready to start with PlexusDx?

Starting at $129/month. See current pricing and start your free consultation.